Reductions in glial reactivity and white matter damage after CCH may contribute to the neuroprotective effects observed in the RES group, and these effects may be related to the inhibition of STING/TBK1/IRF3 signaling. This evidence concerns the gene TBK1 and columnar cell hyperplasia of the breast.